Vaginal matrix metalloproteinase levels in pregnant women with bacterial vaginosis

J Soc Gynecol Investig. 2006 Sep;13(6):430-4. doi: 10.1016/j.jsgi.2006.05.008. Epub 2006 Jul 26.

Abstract

Objective: To compare matrix metalloproteinase (MMP)-8 and MMP-9 levels in the vaginal secretions of pregnant women with or without asymptomatic bacterial vaginosis (BV).

Methods: In this study, vaginal levels and molecular forms of MMP-8 and MMP-9 were studied in 36 pregnant women between 28 and 34 weeks of gestation with asymptomatic BV and 41 pregnant women, matched for gestational age, without BV.

Results: Vaginal MMP-8 concentrations were significantly higher (P = .023) in BV-positive women. There was no significant difference in MMP-9 levels between healthy pregnant controls and BV-positive pregnant women. The presence of MMP-8 was confirmed by a 38-kd band on Western blots.

Conclusions: Our findings show that BV is associated with increased levels of MMP-8 in vaginal fluid. Increased production of collagen-degrading enzymes such as MMP-8 is a possible cause of spontaneous preterm delivery in pregnant women with asymptomatic BV.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Blotting, Western
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gestational Age
  • Humans
  • Matrix Metalloproteinase 8 / analysis
  • Matrix Metalloproteinase 9 / analysis
  • Matrix Metalloproteinases / analysis*
  • Obstetric Labor, Premature / enzymology
  • Parity
  • Pregnancy
  • Pregnancy Complications, Infectious / enzymology*
  • Vagina / enzymology*
  • Vaginosis, Bacterial / enzymology*

Substances

  • Matrix Metalloproteinases
  • Matrix Metalloproteinase 8
  • Matrix Metalloproteinase 9